Figure 1 (Lacosamide Fig1)
Lacosamide Solution
Product Images NDC 72603-305
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 72603-305). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2 (Lacosamide Fig2)
Figure 2 provides the data on the proportion of patients categorized by responder rate for the Lacosamide and Placebo groups in Studies 2, 3, and 4. The chart illustrates the response rates for different doses of Lacosamide (200mg/day, 400mg/day, 600mg/day) compared to Placebo, based on the total number of patients in each group. The chart shows the percentage of patients falling into specific responder rate categories.*
Figure 3 (Lacosamide Fig3)
Package Label-principal Display Panel (10 mg/mL Container (200mL))
This is a label for Lacosamide Oral Solution, USP containing 10 mg/ml. The medication guide should be provided to each patient. Phenylketonurics should note that the solution contains 0.27 mg of phenylalanine per 200 mg dose. The normal dosage instructions can be found in the package insert. The solution should be stored between 20°C to 25°C. Unused product should be discarded after six months of first opening. The medication should be kept out of reach of children. The original container should be used for dispensing. Manufacturer information is provided for Northstar Rx LLC in Memphis, TN and Aurobindo Pharma Limited in India. Contact information for additional Medication Guides is included.*
Chemical Structure (Lacosamide Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
